Current Research Projects approved for three years 2022 – 2024
- Precision medicine: study of deregulated functional networks in neoplasms by integrated proteomic and metabolomic analysis
- Use of “omic” approaches for the study of the pathogenetic mechanisms underlying neurodegenerative and neurodevelopmental diseases, to search biomarkers and molecular targets useful in the prognosis and to develop drug therapies
- Rational design, synthesis and characterization of molecules of therapeutic interest and their transport through nanovectors. Reposition of existing drugs through computational simulations; evaluations of efficacy and toxicity
- Development and implementation of algorithms and innovative software to support oncology research
